Marc-Oliver K.
- Country
- Germany
- Department
- Institut für klinische Forschung Pneumologie
Research Overview
- Evaluation of GSK3862995B in Healthy Subjects and Patients with Chronic Obstructive Pulmonary Disease
- Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics of AZD8630 in Adults with Asthma on Medium-to-High Dose Inhaled Corticosteroids and Long-Acting Beta-Agonists
- Phase 1 Study of JNJ-95597528: Safety, Tolerability, and Pharmacokinetics in Healthy Subjects and Mechanism Proof in Mild to Moderate Asthma
Data & Insights
Has run more than one trial at 442 of 1020 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in treating patients with moderate to severe asthma, with particular emphasis on cases where conventional treatments have provided inadequate control.
- Asthma Management
- Pulmonary Function Assessment
- Novel Therapeutic Approaches
Their research focuses on evaluating innovative therapeutic options for patients with persistent respiratory symptoms despite standard treatments.
Therapeutic Innovation
The investigator conducts research in advanced therapeutic interventions, specifically examining new compounds for respiratory conditions.
- Treatment Efficacy Evaluation
- Safety Assessment
- Clinical Outcomes
Their work encompasses the evaluation of novel medicinal products for patients with respiratory disorders requiring enhanced therapeutic options.
Clinical Assessment
The investigator specializes in pulmonary function testing and comprehensive evaluation of respiratory treatments.
- Response Monitoring
- Treatment Optimization
- Patient Assessment
Their expertise includes detailed analysis of respiratory function and therapeutic response in patients with challenging asthma presentations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.